Table 2 Demographic and clinical characteristics
Characteristics | Total | Temperature sensitive | Temperature non-sensitive | P* |
|---|---|---|---|---|
N = 66 | N = 34 | N = 32 | ||
Age, year | 43.3 ± 12.9 | 42.6 ± 12.3 | 44.0 ± 13.8 | 0.675 |
Female, N (%) | 50 (75.8 %) | 27 (79.4) | 23 (71.9) | 0.671 |
Age of onset, year | 24.5 ± 13.8 | 20.3 ± 9.8 | 29.1 ± 16.0 | 0.009 |
Duration of illness, year | 18.8 ± 13.6 | 22.4 ± 13.1 | 14.9 ± 13.2 | 0.025 |
Headache days per month, all severity | 6.3 ± 6.2 | 5.4 ± 5.0 | 7.2 ± 7.4 | 0.262 |
Headache days per month, moderate or severe | 3.0 ± 3.2 | 2.1 ± 1.1 | 4.0 ± 4.2 | 0.012 |
Acute treatment, N (%) | ||||
Sumatriptan | 42 (63.6) | 22 (64.7) | 20 (62.5) | 1.000 |
NSAIDs | 37 (56.1) | 22 (64.7) | 15 (46.9) | 0.225 |
Preventive treatment, N (%) | ||||
Propranolol | 40 (60.6) | 20 (58.8) | 20 (62.5) | 1.000 |
Anti-convulsants | 20 (30.3) | 12 (35.4) | 8 (25.0) | 0.522 |
Flunarizine | 13 (19.7) | 8 (23.5) | 5 (15.6) | 0.617 |
Anti-depressants | 12 (18.1) | 7 (20.6) | 5 (15.6) | 0.841 |
Either one | 56 (84.8) | 27 (79.4) | 29 (90.6) | 0.198 |
Hypertension | 2 (3.0) | 1 (2.9) | 1 (3.1) | 0.498 |
Diabetes | 6 (9.1) | 3 (8.8) | 3 (9.4) | 1.000 |